BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Siegfried Acquires Alliance Medical Products


5/31/2012 8:58:07 AM

Zofingen, Mai 31, 2012 -- Effective immediately, Siegfried Holding AG (SIX: SFZN) has acquired Alliance Medical Products, Inc. (AMP), Irvine, California. This acquisition gives Siegfried an entry into the custom market for sterile filling services.

Complementing the company’s technology base with competency in sterile filling services is a strategic goal for the Siegfried Group. By taking over 100% of the shares of privately-held Alliance Medical Products (AMP), the Swiss pharmaceutical supplier makes a substantial step toward additional profitable growth. The purchase price of $58 million is to be paid immediately, with a contingent earn-out to be paid if defined profitability goals have been met for the fiscal year ended December 31, 2013. The transaction is expected to be accretive already in 2012.

Attractive company with solid track record

Founded in 2001, AMP is based in Irvine, California and provides sterile filling services for medications – an attractive segment of the pharmaceutical custom market. The company achieved revenues of $20 million in 2011 with approximately 100 employees.

AMP is operating profitably, has an attractive client base and a substantial project pipeline. The company is expected to continue its growth and provide a strong contribution to the equity value of the Siegfried Group. In order to ensure a seamless integration the management of AMP will remain in place.

Various synergies

The acquisition provides various synergies for both companies, especially in the areas of technology and marketing. Dr. Rudolf Hanko, Siegfried CEO, explains: “Siegfried is one of the few companies with capabilities in both pharmaceutical and chemical manufacturing. Our acquisition of AMP expands this exceptional offer into the sterile filling market, a particularly attractive segment. Integrating AMP into the Siegfried Group is an asset for both companies.”

Juan Valdes, AMP CEO, adds: “Our association with Siegfried opens interesting growth and expansion possibilities for AMP. The combination of sterile filling services with the production of active pharmaceutical ingredients is unique in the custom manufacturing market.”

Siegfried will hold a conference call at 2.00 p.m (CET). The coordinates are as follows:

Dial-in number

0800 002 145

+41 (0)22 580 59 81

+41 (0)44 580 33 40

Participants PIN: 93233313#

The presentation prior to the conference call will be uploaded to the website at 1.00 p.m. (CET)

For further information:

Peter Gehler, Head Corporate Center

peter.gehler@siegfried.ch

Phone +41 (0)62 746 11 48

Mobile +41 (079) 416 41 16

Fax +41 (0)62 746 11 03

Siegfried Holding AG

Untere Brühlstrasse 4

CH-4800 Zofingen

Pone +41 (0)62 746 11 11

Fax +41 (0)62 746 11 03

www.siegfried.ch

www.amp-us.com

About Siegfried

The Siegfried Group is active worldwide in the field of Life Sciences with production facilities located in Switzerland, Malta and the USA. At the end of 2011, Siegfried employed approximately 700 employees and reported annual sales of CHF 328 million. Siegfried Holding AG is listed on the Swiss Exchange (SIX: SFZN). Siegfried is active in both the primary and secondary production of drugs. The company develops and manufactures active pharmaceutical ingredients for the research-based pharmaceutical industry as well as the corresponding intermediate steps and controlled substances, and provides development and production services for drugs in finished dosage forms.

About Alliance Medical Products

Alliance Medical Products is a full service FDA, MHRA and ISO13485 certified Contract Manufacturing Organization (CMO), who provides pharmaceutical companies with a complete single source solution from early stage through high volume commercial manufacturing.

With over 100 employees in its Irvine California location, Alliance Medical Products offers custom fill finish services in sterile liquid, suspension, emulsion, ointments and specialty combo delivery devices, with a focus on unique and difficult to manufacture products.


Read at BioSpace.com


   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->